Tag: pharmaceutical drugs

November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
May 9, 2018

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...
May 7, 2018

Isodiol International Inc. Increases Size of Non-Brokered Offering and Retains Clarus Securities as Financial Advisor

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical,...
May 4, 2018

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...
May 2, 2018

Isodiol International Inc. Announces Binding Agreement to Acquire 51% of Farmtiva and Commence Hemp Farming in California

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical...
May 1, 2018

Isodiol International Inc. Completes Acquisition of KURE™ Corp

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical...
April 26, 2018

Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient

Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F), a global CBD innovator specializing in the development of pharmaceutical actives and health and...